Smart Pharma SPRL
1.1 FTEThe score of Smart Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -48 % Total assets -12 % Headcount (avg FTE) +10 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Smart Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −37,265 € | ||||
| Equity | 84,109 € | ||||
| Cash | 15,179 € | ||||
| EBITDA | −18,015 € | ||||
| Total assets | 483,477 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 27 Jul 2022
Smart Pharma's financial analysis
- Solvency17.4%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Smart Pharma
Smart Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0588.980.436
- VAT number
- BE0588980436
- Peppol
- Registered · 0208:0588980436 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 29 Jan 2015
- Registered office
- 1050 Ixelles
- Size
- Micro · 1.1 FTE
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Smart Pharma (SPRL) has been based in Ixelles since 2015, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 37,265 € and equity of 84,109 €; its revenue is not published. With 1.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 17.4%, below the median of its sector (37.8%).
Companies similar to Smart Pharma
Companies in the same business, of comparable size and area, outside its group.
- Infinium Business and other management consultancy activities Keerbergen · balance sheet 519,554 €
- MTLB Healthcare Consulting Business and other management consultancy activities Enghien · balance sheet 298,148 €
- OTC Diffusion Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Saint-Gilles · balance sheet 318,948 €
- Medicina Legatis Business and other management consultancy activities Anderlecht · balance sheet 61,365 €
- Virkur Business and other management consultancy activities Aalst · balance sheet 52,966 €
- Strybol Trui Apotheek Retail sale of pharmaceutical products Bruges · balance sheet 397,630 €
- Apotheek Vandeperre LUT Retail sale of pharmaceutical products Meerhout · balance sheet 509,176 €
- Pharmacie DE LA Tour Retail sale of pharmaceutical products Anderlues · balance sheet 490,336 €
Frequently asked questions about Smart Pharma
What is the revenue of Smart Pharma?
Smart Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Smart Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0588980436 for Smart Pharma, if the company is VAT-registered. Its company number (CBE) is 0588.980.436.
Where is the registered office of Smart Pharma?
According to the CBE register, the registered office of Smart Pharma is in 1050 Ixelles.
What is the equity of Smart Pharma?
At the close of the 2025 financial year, the equity of Smart Pharma amounts to 84,109 €, a solvency of 17.4% of total assets.
How many people work at Smart Pharma?
1.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Smart Pharma?
The register lists 3 active mandates at Smart Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Smart Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →